Logo - RBT.jpg
Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19
June 23, 2020 09:00 ET | Rénibus Therapeutics Inc.
DALLAS, Texas, June 23, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it has been granted Fast Track designation by the FDA for...
Amid Shock of Sky-Hi
Amid Shock of Sky-High COVID-19 Medical Costs, National Nonprofit Pledges Help and Hope
June 10, 2020 11:08 ET | Help Hope Live
Radnor, PA, June 10, 2020 (GLOBE NEWSWIRE) -- Amid the extreme uncertainty surrounding the cost of COVID-19 medical care, the national nonprofit Help Hope Live (helphopelive.org) has announced that...
FBI LOGO TM.png
Covid-19 Treatment Options May Unfold Soon; Several Companies Initiate Phase-4 Clinical Trials, says Fortune Business Insights™
April 20, 2020 09:36 ET | Fortune Business Insights
Pune, April 20, 2020 (GLOBE NEWSWIRE) -- The corona virus pandemic has alarmed people across the world. Given its potential to have a toll on the human life, strict measures are being taken to...
SNWV.png
SANUWAVE Health Announces Successful Filing of Patent for Use of Shockwaves to Treat Respiratory Ailments, Including Viral Infections Such as COVID-19 
April 09, 2020 14:00 ET | SANUWAVE Health, Inc.
Concept Submitted to National Science Foundation for Funding Grant SUWANEE, GA, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today the...
CBondlogo-Red.png
C-Bond Systems Secures Strategic Partnership with MACOMA Environmental Technologies to Sell FN® NANO Photocatalytic Coatings to Combat Pathogen and Virus Spread Such as COVID-19 and MRSA
March 26, 2020 08:31 ET | C-Bond Systems
HOUSTON, March 26, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology company that improves and strengthens glass, today announced it has...